Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1995; 88(Suppl 25): 37–40.
PMCID: PMC1295057

Post heart/lung transplantation management.


Patients with cystic fibrosis present a challenge to management post-transplantation but the results are comparable with those obtained in patients with other conditions. The increasing population of cystic fibrosis patients who have undergone transplantation will require joint management of such patients by cystic fibrosis specialists and pulmonary transplant specialists. The follow-up of patients with cystic fibrosis following pulmonary transplantation potentially affords us an exciting opportunity to study the natural history of this disease as it affects the extra pulmonary organs.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (662K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Shennib H, Adoumie R, Noirclerc M. Current status of lung transplantation for cystic fibrosis. Arch Intern Med. 1992 Aug;152(8):1585–1588. [PubMed]
  • Massard G, Shennib H, Metras D, Camboulives J, Viard L, Mulder DS, Tchervenkov CI, Morin JF, Giudicelli R, Noirclerc M. Double-lung transplantation in mechanically ventilated patients with cystic fibrosis. Ann Thorac Surg. 1993 May;55(5):1087–1092. [PubMed]
  • Dennis C, Caine N, Sharples L, Smyth R, Higenbottam T, Stewart S, Wreghitt T, Large S, Wells FC, Wallwork J. Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth Hospital. J Heart Lung Transplant. 1993 Nov-Dec;12(6 Pt 1):893–902. [PubMed]
  • Smyth RL, Higenbottam TW, Scott JP, Wreghitt TG, Stewart S, Clelland CA, McGoldrick JP, Wallwork J. Herpes simplex virus infection in heart-lung transplant recipients. Transplantation. 1990 Apr;49(4):735–739. [PubMed]
  • Gould FK, Freeman R, Taylor CE, Ashcroft T, Dark JH, Corris PA. Prophylaxis and management of cytomegalovirus pneumonitis after lung transplantation: a review of experience in one center. J Heart Lung Transplant. 1993 Jul-Aug;12(4):695–699. [PubMed]
  • Berry GJ, Brunt EM, Chamberlain D, Hruban RH, Sibley RK, Stewart S, Tazelaar HD. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant. 1990 Nov-Dec;9(6):593–601. [PubMed]
  • Salter MM, Kirklin JK, Bourge RC, Naftel DC, White-Williams C, Tarkka M, Waits E, Bucy RP. Total lymphoid irradiation in the treatment of early or recurrent heart rejection. J Heart Lung Transplant. 1992 Sep-Oct;11(5):902–912. [PubMed]
  • Milne DS, Gascoigne AD, Ashcroft T, Sviland L, Malcolm AJ, Corris PA. Organizing pneumonia following pulmonary transplantation and the development of obliterative bronchiolitis. Transplantation. 1994 Jun 27;57(12):1757–1762. [PubMed]
  • Bachrach LK, Loutit CW, Moss RB. Osteopenia in adults with cystic fibrosis. Am J Med. 1994 Jan;96(1):27–34. [PubMed]
  • Nagington J, Gray J. Cyclosporin A immunosuppression, Epstein-Barr antibody, and lymphoma. Lancet. 1980 Mar 8;1(8167):536–537. [PubMed]
  • Armitage JM, Kormos RL, Stuart RS, Fricker FJ, Griffith BP, Nalesnik M, Hardesty RL, Dummer JS. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant. 1991 Nov-Dec;10(6):877–887. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press